These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29322838)

  • 1. Chronic myelomonocytic leukemia with central nervous system involvement.
    Hannon M; Wilde L; Nwaoduah N; Kasner M
    Leuk Lymphoma; 2018 Sep; 59(9):2267-2268. PubMed ID: 29322838
    [No Abstract]   [Full Text] [Related]  

  • 2. Azacitidine followed by radiotherapy as effective treatment for chronic myelomonocytic leukemia with extramedullary localization.
    Serrao A; Loglisci G; Salaroli A; Zacheo I; Alimena G; Breccia M
    Leuk Lymphoma; 2013 Feb; 54(2):411-2. PubMed ID: 22694794
    [No Abstract]   [Full Text] [Related]  

  • 3. Haploidentical stem cell transplantation in patients with chronic myelomonocytic leukemia.
    Sun YQ; Zhao C; Wang Y; Yan CH; Zhang XH; Xu LP; Liu KY; Huang XJ
    Sci China Life Sci; 2020 Aug; 63(8):1261-1264. PubMed ID: 32086671
    [No Abstract]   [Full Text] [Related]  

  • 4. Central nervous system relapse of primary cutaneous CD8
    Oun H; Wilson M; Leach M; McKay P
    Br J Haematol; 2021 Apr; 193(1):9. PubMed ID: 33336793
    [No Abstract]   [Full Text] [Related]  

  • 5. [The trial use of alpha-IFN in treating a case of chronic myelomonocytic leukemia with splenic infarction].
    Kimura S; Yokoo K; Ozawa M; Kobayashi Y; Horiuchi H; Kondo M
    Gan No Rinsho; 1989 Apr; 35(5):615-9. PubMed ID: 2716192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia: a way to improve the outcome?
    Niscola P; Cupelli L; Dentamaro T; de Fabritiis P
    Leuk Res; 2016 Mar; 42():80-1. PubMed ID: 26790726
    [No Abstract]   [Full Text] [Related]  

  • 7. [Allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia and juvenile myelomonocytic leukemia].
    Shao Q; Wang ZD; Zheng XL; Dong L; Han DM; Yan HM; Wang HX; Duan LN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1058-62. PubMed ID: 25130828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dismal outcome of acute myeloid leukemia secondary to myelodysplastic syndrome and chronic myelomonocytic leukemia after azacitidine failure in a daily-life setting.
    Niscola P; Tendas A; Cupelli L; Giovannini M; Piccioni D; Scaramucci L; Dentamaro T; Del Poeta G; de Fabritiis P
    Acta Haematol; 2015; 133(1):64-6. PubMed ID: 25139255
    [No Abstract]   [Full Text] [Related]  

  • 9. Monocytic skin nodules in chronic myelomonocytic leukemia: clinical response to decitabine therapy.
    Steensma DP; Friday BB
    Leuk Lymphoma; 2007 Aug; 48(8):1628-9. PubMed ID: 17701595
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety of liposomal cytarabine CNS prophylaxis in children, adolescent and young adult hematopoietic stem cell transplant recipients with acute leukemia and non-Hodgkin lymphoma.
    Hochberg J; Harrison L; Morris E; Militano O; Brand P; Fabricatore S; Wolownik K; Cairo MS
    Bone Marrow Transplant; 2016 Sep; 51(9):1249-52. PubMed ID: 27088378
    [No Abstract]   [Full Text] [Related]  

  • 11. Addition of High-Dose Cytarabine to Fludarabine-Based Conditioning for Hematopoietic Stem Cell Transplantation for Treating Fanconi Anemia Patients with Advanced Myeloid Malignancy: A Single-Center Experience and Literature Review.
    Aoki T; Koh K; Ikeda Y; Sekinaka Y; Akiyama K; Mori M; Arakawa Y; Hanada R
    Biol Blood Marrow Transplant; 2016 Sep; 22(9):1725-1728. PubMed ID: 27246371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
    Mittal P; Saliba RM; Giralt SA; Shahjahan M; Cohen AI; Karandish S; Onida F; Beran M; Champlin RE; de Lima M
    Bone Marrow Transplant; 2004 May; 33(10):1005-9. PubMed ID: 15048141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypomethylating Agents as Bridging Therapy before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chronic Myelomonocytic Leukemia?
    Robin M; Fenaux P
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):1-2. PubMed ID: 26576835
    [No Abstract]   [Full Text] [Related]  

  • 14. Cognitive functions in primary central nervous system lymphoma patients treated with chemotherapy and stem cell transplantation: preliminary findings.
    Correa D; Anderson ND; Glass A; Mason WP; DeAngelis LM; Abrey LE
    Clin Adv Hematol Oncol; 2003 Aug; 1(8):490. PubMed ID: 16258439
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytogenetic risk stratification may predict allogeneic hematopoietic stem cell transplantation outcomes for chronic myelomonocytic leukemia.
    Motohashi K; Fujisawa S; Doki N; Kobayashi T; Mori T; Usuki K; Tanaka M; Fujiwara S; Kako S; Aoyama Y; Onoda M; Yano S; Gotoh M; Kanamori H; Takahashi S; Okamoto S;
    Leuk Lymphoma; 2018 Jun; 59(6):1332-1337. PubMed ID: 29032731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of performance status and transfusion dependency on outcome of patients with myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia treated with azacitidine (PIAZA study).
    Wehmeyer J; Zaiss M; Losem C; Schmitz S; Niemeier B; Harde J; Hannig CV; Harich HD; Müller J; Klausmann M; Tessen HW; Potthoff K
    Eur J Haematol; 2018 Dec; 101(6):766-773. PubMed ID: 30091166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningeal involvement of chronic myelomonocytic leukemia.
    Aoyama K; Ishikura H; Tsumura H; Watanabe T; Suyama N; Kumakura S; Kobayashi S
    J Neurol; 2003 Aug; 250(8):993-4. PubMed ID: 12928923
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia.
    Pophali P; Matin A; Mangaonkar AA; Carr R; Binder M; Al-Kali A; Begna KH; Reichard KK; Alkhateeb H; Shah MV; Tefferi A; Hogan WJ; Litzow MR; Patnaik MM
    Blood Cancer J; 2020 Nov; 10(11):121. PubMed ID: 33219206
    [No Abstract]   [Full Text] [Related]  

  • 19. The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement.
    Castagnola C; Nozza A; Corso A; Bernasconi C
    Haematologica; 1997; 82(5):577-80. PubMed ID: 9407724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system involvement in T-cell lymphoma: A single center experience.
    Gurion R; Mehta N; Migliacci JC; Zelenetz A; Moskowitz A; Lunning M; Moskowitz C; Hamlin P; Horwitz S
    Acta Oncol; 2016 May; 55(5):561-6. PubMed ID: 27046135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.